{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T13:14:08Z","timestamp":1722345248436},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"9","funder":[{"DOI":"10.13039\/100015237","name":"The Medicines Company","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s12325-016-0381-y","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T05:01:14Z","timestamp":1468645274000},"page":"1649-1659","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fentanyl Iontophoretic Transdermal System (IONSYS\u00ae) can be Safely used in the Hospital Environment with X-Rays, Computerized Tomography and Radiofrequency Identification Devices"],"prefix":"10.1007","volume":"33","author":[{"given":"John","family":"Lemke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmond","family":"Sardariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Bradley","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niki","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loretta M.","family":"Itri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Caravelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene R.","family":"Viscusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,16]]},"reference":[{"key":"381_CR1","unstructured":"The Medicines Company. IONSYS (fentanyl iontophoretic transdermal system), CII Prescribing Information. 2015. http:\/\/www.ionsys.com\/pdfs\/ionsys-prescribing-information.pdf . Accessed 19 May 2016."},{"issue":"2","key":"381_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2217\/pmt.15.70","volume":"6","author":"N Joshi","year":"2016","unstructured":"Joshi N, Lemke J, Danesi H. Design and functionality of a smart fentanyl iontophoretic transdermal system for the treatment of moderate-to-severe postoperative pain. Pain Manag. 2016;6(2):137\u201345.","journal-title":"Pain Manag"},{"key":"381_CR3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1213\/01.ANE.0000093314.13848.7E","volume":"98","author":"JE Chelly","year":"2004","unstructured":"Chelly JE, Grass J, Houseman TW, Minkowitz H, Pue A. The safety and efficacy of a fentanyl patient-controlled transdermal system for acute postoperative analgesia: a multicenter, placebo-controlled trial. Anesth Analg. 2004;98:427\u201333 (table of contents).","journal-title":"Anesth Analg."},{"key":"381_CR4","unstructured":"The Medicines Company. Data on file. Parisppany:NJ; 2014."},{"key":"381_CR5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1213\/01.ane.0000183649.58483.77","volume":"102","author":"ER Viscusi","year":"2006","unstructured":"Viscusi ER, Reynolds L, Tait S, Melson T, Atkinson LE. An iontophoretic fentanyl patient-activated analgesic delivery system for postoperative pain: a double-blind, placebo-controlled trial. Anesth Analg. 2006;102:188\u201394.","journal-title":"Anesth Analg"},{"key":"381_CR6","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.291.11.1333","volume":"291","author":"ER Viscusi","year":"2004","unstructured":"Viscusi ER, Reynolds L, Chung F, Atkinson LE, Khanna S. Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. JAMA. 2004;291:1333\u201341.","journal-title":"JAMA"},{"key":"381_CR7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/bja\/aem102","volume":"98","author":"S Grond","year":"2007","unstructured":"Grond S, Hall J, Spacek A, Hoppenbrouwers M, Richarz U, Bonnet F. Iontophoretic transdermal system using fentanyl compared with patient-controlled intravenous analgesia using morphine for postoperative pain management. Br J Anaesth. 2007;98:806\u201315.","journal-title":"Br J Anaesth"},{"key":"381_CR8","first-page":"546","volume":"31","author":"CT Hartrick","year":"2006","unstructured":"Hartrick CT, Bourne MH, Gargiulo K, Damaraju CV, Vallow S, Hewitt DJ. Fentanyl iontophoretic transdermal system for acute-pain management after orthopedic surgery: a comparative study with morphine intravenous patient-controlled analgesia. Reg Anesth Pain Med. 2006;31:546\u201354.","journal-title":"Reg Anesth Pain Med"},{"key":"381_CR9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1526-4637.2006.00257.x","volume":"8","author":"HS Minkowitz","year":"2007","unstructured":"Minkowitz HS, Rathmell JP, Vallow S, Gargiulo K, Damaraju CV, Hewitt DJ. Efficacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery. Pain Med. 2007;8:657\u201368.","journal-title":"Pain Med."},{"key":"381_CR10","unstructured":"MET Laboratories. Program for testing medical devices for susceptibility to RFID being launched. 2011, http:\/\/www.prweb.com\/releases\/medical-device\/rfid-susceptibility\/prweb8900624.htm . Accessed 1 June 2016)."},{"key":"381_CR11","unstructured":"US Food and Drug Administration. Medical X-ray Imaging. 2016. http:\/\/www.fda.gov\/radiation-emittingproducts\/radiationemittingProductsandProcedures\/MedicalImaging\/MedicalX-Rays\/default.htm . Accessed 22 May 2016."},{"key":"381_CR12","unstructured":"US Food and Drug Administration. NEXT Data Summaries. 2016. http:\/\/www.fda.gov\/radiation-emittingProducts\/RadiationSafety\/nationwideevaluationofX-rayTrendsNEXT\/ucm116508.htm . Accessed 22 May 2016."},{"key":"381_CR13","unstructured":"US Food and Drug Administration. What are the radiation risks from CT? 2016. http:\/\/www.fda.gov\/Radiation-EmittingProducts\/RadiationEmittingProductsandProcedures\/MedicalImaging\/MedicalX-Rays\/ucm115329.htm . Accessed 22 May 2016."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-016-0381-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T01:25:07Z","timestamp":1589678707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-016-0381-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,16]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["381"],"URL":"https:\/\/doi.org\/10.1007\/s12325-016-0381-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,16]]}}}